Cremieux Recueil
Independent researcher specializing in psychometrics, econometrics, and cliometrics, known for quantitative analysis of global biomedical trends.
“China is actually ahead of the U.S. now. And I'm going to show you some documentation of that. Some people haven't realized it yet. It hasn't really leaked to the press at this point.”
Source→“Eli Lilly has these two trials... they wanted to get the full placebo effect size. They have these two trials and what they both have the same inclusion criteria... your control arm for your novel thing, you don't have to actually have a control arm. Just use the control data from that previous trial.”
Source→“Basically he finds drugs that have been abandoned and he looks at them and he goes, oh, this actually helped this like secondary endpoint. Let's go pick up that drug, buy it for cheap because it was abandoned. And then repurpose it for this other thing.”
Source→“I think it'll be very good. You should actually invite the other guy who did the Dana Farber qui tam case on... one guy filed his own case against Dana-Farber for fake images and stuff. Sholto David.”
Source→“Eliezer Masliah, the guy who used to run the NIA's neuroscience division, he was the top researcher globally on Alzheimer's and Parkinson's... And he basically led to the misallocation of billions of dollars in money.”
Source→“It was either Amgen or Gilead did it first... then the actual price on the drug that is paid by the insurers, the net price, came down immediately. Because when you have like 10 drugs in a space, the cost of the drug is like 90% down.”
Source→“He basically led to the misallocation of billions of dollars in money that went to like clinical trials and all this stuff... Tons of people spent time trying to replicate his stuff and it just did not work.”
Source→“Basically he finds drugs that have been abandoned and he looks at them and he goes, oh, this actually helped this like secondary endpoint. Let's go pick up that drug, buy it for cheap because it was abandoned. And then repurpose it for this other thing.”
Source→“He basically led to the misallocation of billions of dollars in money that went to like clinical trials and all this stuff... Tons of people spent time trying to replicate his stuff and it just did not work. So we went down like a tech tree that shouldn't exist.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.